 | ||||||
| Ebola | ||||||
| NEWS | ||||||
| Trump vs. "disease X" Some we know, like the hemorrhagic fevers Ebola, Lassa, and Marburg, which can cause their victims to bleed out from their gums and eyes. But further down on the WHO list was a threat ominously described as "disease X." The X stands for an unknown: a pathogen lurking out there, currently being ...
| ||||||
| No One's Quite Sure Why Lassa Fever Is On The Rise In Nigeria With help from a few partners, it stopped Ebola's spread. It wrestled guinea-worm disease into a headlock, with no new cases since 2013. And it's nearly eradicated the transmission of polio. But now a disease that usually just lurks in the background has roared into headlines. Since the beginning of the ...
| ||||||
| Ebola Virus Vaccine Market Size, Share, Trends Analysis And Growth Forecast By Type And ... Ebola Virus Vaccine Market provides detailed market segment level data on the international market. The Ebola Virus Vaccine Market in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in Ebola Virus Vaccine Industry, with capacity, production, price, ...
| ||||||
| CDC seeks new labs for bioterror pathogens to replace aging facility ATLANTA — Inside a complex of special government labs, scientists in full-body protective suits work with some of the world's deadliest pathogens: Ebola, smallpox and certain strains of bird flu. Many of the organisms have no treatment or vaccine, so the labs housed in this facility on the sprawling ...
| ||||||
| UCD leads effort to fight viruses before they become pandemics Rather than wait for viruses like Ebola, SARS and Zika to become outbreaks that force the world to react, a new global initiative seeks to proactively identify, prepare for and stop viral threats before they become pandemics. The Global Virome Project, described in an article of the same name published ...
| ||||||
| Inovio Pharmaceuticals, Inc. (INO) Analysts See $-0.29 EPS; Shorts at NORDEA AB ORDINARY ... It has completed, current or planned clinical programs of its proprietary SynCon immunotherapies for HPV-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus, hepatitis B virus, HIV, Ebola, Middle East Respiratory Syndrome, and Zika virus.
| ||||||
| EU Civil Protection Mechanism to be strengthened It has also been used following major disasters such as the earthquake in Nepal and the Ebola epidemic. The < emergency.lu > capacity will be deployed to assure stable communication in emergencies to all Participating States of the Mechanism and internationally. Ministers from Luxembourg will take ...
| ||||||
| See more results | Edit this alert | ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar